Clinical Trial Update: A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

View source ↗

Summary

A long-term follow-up study is ongoing to monitor participants with sickle cell disease or transfusion-dependent beta-thalassemia who received EDIT-301; enrollm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Transfusion-dependent Beta-thalassemia

Drugs mentioned

• EDIT-301

Snippet

Sponsor: Editas Medicine, Inc. | Conditions: Sickle Cell Disease, Transfusion-dependent Beta-Thalassemia | Status: ENROLLING_BY_INVITATION